
20 November @ 11:00 am – 12:00 pm CET
Following the launch of the latest edition of Measuring the Economic Footprint of the Biotechnology Industry in the European Union: 2008–2024, join us for a webinar exploring the findings and what they mean for the future of EU biomanufacturing.
The study examines biotechnology’s contribution to the European economy through indicators including economic growth, employment, productivity, trade and R&D, as well as its wider impact across European value chains.
In this webinar, we’ll take a closer look at the latest evidence and discuss what it tells us about the development of Europe’s biotechnology industry and the opportunities ahead.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.